Logo image of SOL

EMEREN GROUP LTD (SOL) Stock Fundamental Analysis

USA - NYSE:SOL - US75971T3014 - ADR

1.87 USD
-0.01 (-0.53%)
Last: 9/23/2025, 1:51:12 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SOL. SOL was compared to 52 industry peers in the Construction & Engineering industry. SOL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SOL is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SOL had positive earnings in the past year.
In the past year SOL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SOL reported negative net income in multiple years.
In the past 5 years SOL always reported negative operating cash flow.
SOL Yearly Net Income VS EBIT VS OCF VS FCFSOL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.08%, SOL is doing worse than 69.23% of the companies in the same industry.
The Return On Equity of SOL (-1.65%) is worse than 69.23% of its industry peers.
Industry RankSector Rank
ROA -1.08%
ROE -1.65%
ROIC N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
SOL Yearly ROA, ROE, ROICSOL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

SOL has a better Gross Margin (26.87%) than 76.92% of its industry peers.
In the last couple of years the Gross Margin of SOL has declined.
SOL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
SOL Yearly Profit, Operating, Gross MarginsSOL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

5

2. Health

2.1 Basic Checks

SOL does not have a ROIC to compare to the WACC, probably because it is not profitable.
SOL has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SOL has more shares outstanding
Compared to 1 year ago, SOL has a worse debt to assets ratio.
SOL Yearly Shares OutstandingSOL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SOL Yearly Total Debt VS Total AssetsSOL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.46, we must say that SOL is in the distress zone and has some risk of bankruptcy.
SOL has a Altman-Z score of -0.46. This is amonst the worse of the industry: SOL underperforms 86.54% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that SOL is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.17, SOL is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -0.46
ROIC/WACCN/A
WACC9.73%
SOL Yearly LT Debt VS Equity VS FCFSOL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 4.03 indicates that SOL has no problem at all paying its short term obligations.
The Current ratio of SOL (4.03) is better than 100.00% of its industry peers.
A Quick Ratio of 4.03 indicates that SOL has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.03, SOL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 4.03
SOL Yearly Current Assets VS Current LiabilitesSOL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 215.38% over the past year.
The Revenue for SOL has decreased by -12.85% in the past year. This is quite bad
The Revenue has been decreasing by -5.02% on average over the past years.
EPS 1Y (TTM)215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5500%
Revenue 1Y (TTM)-12.85%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-57.14%

3.2 Future

SOL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.80% yearly.
The Revenue is expected to grow by 11.79% on average over the next years. This is quite good.
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOL Yearly Revenue VS EstimatesSOL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
SOL Yearly EPS VS EstimatesSOL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.16, the valuation of SOL can be described as very cheap.
Based on the Price/Earnings ratio, SOL is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of SOL to the average of the S&P500 Index (27.41), we can say SOL is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.03, the valuation of SOL can be described as very reasonable.
98.08% of the companies in the same industry are more expensive than SOL, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SOL to the average of the S&P500 Index (22.87), we can say SOL is valued rather cheaply.
Industry RankSector Rank
PE 4.16
Fwd PE 9.03
SOL Price Earnings VS Forward Price EarningsSOL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SOL's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.15
SOL Per share dataSOL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

SOL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SOL's earnings are expected to grow with 72.80% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y72.8%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SOL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMEREN GROUP LTD

NYSE:SOL (9/23/2025, 1:51:12 PM)

1.87

-0.01 (-0.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-19 2025-08-19/amc
Earnings (Next)11-12 2025-11-12/amc
Inst Owners42.92%
Inst Owner Change0.19%
Ins Owners1.06%
Ins Owner Change0%
Market Cap95.97M
Analysts80
Price Target4.59 (145.45%)
Short Float %16.97%
Short Ratio5.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-92.82%
Min EPS beat(2)-384.65%
Max EPS beat(2)199.01%
EPS beat(4)2
Avg EPS beat(4)-67.17%
Min EPS beat(4)-384.65%
Max EPS beat(4)199.01%
EPS beat(8)3
Avg EPS beat(8)-824.63%
EPS beat(12)4
Avg EPS beat(12)-552.14%
EPS beat(16)6
Avg EPS beat(16)-418.14%
Revenue beat(2)0
Avg Revenue beat(2)-27.74%
Min Revenue beat(2)-40.72%
Max Revenue beat(2)-14.76%
Revenue beat(4)1
Avg Revenue beat(4)-16.47%
Min Revenue beat(4)-51.47%
Max Revenue beat(4)41.07%
Revenue beat(8)2
Avg Revenue beat(8)-16.8%
Revenue beat(12)3
Avg Revenue beat(12)-22.58%
Revenue beat(16)3
Avg Revenue beat(16)-24.91%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 4.16
Fwd PE 9.03
P/S 1.12
P/FCF N/A
P/OCF 159.16
P/B 0.32
P/tB 0.32
EV/EBITDA 26.15
EPS(TTM)0.45
EY24.06%
EPS(NY)0.21
Fwd EY11.07%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.01
OCFY0.63%
SpS1.67
BVpS5.92
TBVpS5.92
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.08%
ROE -1.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.87%
FCFM N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
F-Score5
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 13.21
Cap/Depr 213.85%
Cap/Sales 18.16%
Interest Coverage N/A
Cash Conversion 15.52%
Profit Quality N/A
Current Ratio 4.03
Quick Ratio 4.03
Altman-Z -0.46
F-Score5
WACC9.73%
ROIC/WACCN/A
Cap/Depr(3y)305.97%
Cap/Depr(5y)240.17%
Cap/Sales(3y)29.54%
Cap/Sales(5y)22.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5500%
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.85%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-57.14%
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y101.27%
OCF growth 3YN/A
OCF growth 5YN/A